Despite the COVID-19 pandemic and its profound impact on the entire world, 2020 was a good year for Medfiles. Many new deals were closed and attractive revenues generated by serving our clients in the best possible way. Let us have a closer look at the past year:
- In May 2020, Gregory Ambra was appointed as the new CEO of Medfiles Ltd.
- Ninokata Norifumi was nominated as the new President.
- A new Cyber Security Incident Response Team (CSIRT) was established by the IT department in order to better respond to new cyber security challenges.
Clinical study services
- Medfiles and its sister company DZS Clinical Services reinforced their mutual collaboration and initiated several joint projects.
- A set of new SOPs was compiled to ensure conformity with the MDR regulation and the updated ISO 14155 standard.
- A new Agatha eTMF system was taken in use in the EU area.
Laboratory services
- QP certification service was activated.
- Medfiles passed Fimea’s GMP inspection successfully with no major or critical findings.
- Data integrity compliance was improved with new systems and equipment.
- New technology in the form of a rotary benchtop tablet press was introduced to strengthen R&D and laboratory operations.
Regulatory affairs
- Data management of the client projects was further enhanced.
- Several external trainings were organised by MD and IVD team.
- Food unit helped their clients in several novel food projects.
- Regulatory services related to feed and cosmetics were added to the Food unit’s service portfolio.
- The PV team was reinforced with new employees and the EU QPPV services were improved by introducing new resources.
Contact our experts directly for business collaboration or write to for service-specific queries.
Follow us on LinkedIn to stay up-to-date on the latest industry news.
